Muthiah Vaduganathan

86.3k total citations · 15 hit papers
625 papers, 19.2k citations indexed

About

Muthiah Vaduganathan is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Muthiah Vaduganathan has authored 625 papers receiving a total of 19.2k indexed citations (citations by other indexed papers that have themselves been cited), including 462 papers in Cardiology and Cardiovascular Medicine, 198 papers in Endocrinology, Diabetes and Metabolism and 102 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Muthiah Vaduganathan's work include Heart Failure Treatment and Management (330 papers), Cardiovascular Function and Risk Factors (175 papers) and Diabetes Treatment and Management (154 papers). Muthiah Vaduganathan is often cited by papers focused on Heart Failure Treatment and Management (330 papers), Cardiovascular Function and Risk Factors (175 papers) and Diabetes Treatment and Management (154 papers). Muthiah Vaduganathan collaborates with scholars based in United States, United Kingdom and Netherlands. Muthiah Vaduganathan's co-authors include Gregg C. Fonarow, Scott D. Solomon, Javed Butler, John J.V. McMurray, Stephen J. Greene, Mihai Gheorghiade, Orly Vardeny, Brian Claggett, Marc A. Pfeffer and Andrew P. Ambrosy and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Muthiah Vaduganathan

574 papers receiving 18.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Global Health and Economic Burden of Hospitalizations for Heart Failure

2014 1.5k citations Andrew P. Ambrosy, Muthiah Vaduganathan et al. Journal of the American College of Cardiology profile →
Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19

2020 1.4k citations Muthiah Vaduganathan, Orly Vardeny et al. profile →
Rehospitalization for Heart Failure

2012 556 citations Muthiah Vaduganathan, Robert O. Bonow et al. Journal of the American College of Cardiology profile →
SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials

2022 491 citations Muthiah Vaduganathan, Kieran F. Docherty et al. profile →
Twenty Year Trends and Sex Differences in Young Adults Hospitalized With Acute Myocardial Infarction

2019 452 citations Sameer Arora, George A. Stouffer et al. Circulation profile →
Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials

2020 362 citations Muthiah Vaduganathan, Brian Claggett et al. profile →
Titration of Medical Therapy for Heart Failure With Reduced Ejection Fraction

2019 303 citations Muthiah Vaduganathan et al. Journal of the American College of Cardiology profile →
Screening and Management of Depression in Patients With Cardiovascular Disease

2019 216 citations Arman Qamar, Muthiah Vaduganathan et al. Journal of the American College of Cardiology profile →
Prevalence of Cardiovascular-Kidney-Metabolic Syndrome Stages in US Adults, 2011-2020

2024 157 citations Rahul Aggarwal, John W. Ostrominski et al. profile →
Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria

2023 132 citations Brendon L. Neuen, Hiddo J.L. Heerspink et al. Circulation profile →
Prevalence and Overlap of Cardiac, Renal, and Metabolic Conditions in US Adults, 1999-2020

2023 107 citations John W. Ostrominski, Suzanne V. Arnold et al. profile →
Mineralocorticoid receptor antagonists in heart failure: an individual patient level meta-analysis

2024 52 citations Pardeep S. Jhund, Brian Claggett et al. profile →
Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes

2025 44 citations Hiddo J.L. Heerspink, Peter Rossing et al. profile →
Cardiovascular, Kidney, and Safety Outcomes With GLP-1 Receptor Agonists Alone and in Combination With SGLT2 Inhibitors in Type 2 Diabetes: A Systematic Review and Meta-Analysis

2024 43 citations Brendon L. Neuen, Robert A. Fletcher et al. Circulation profile →
Near-universal prevalence of central adiposity in heart failure with preserved ejection fraction: the PARAGON-HF trial

2025 35 citations Muthiah Vaduganathan, Brian Claggett et al. profile →

Peers

Countries citing papers authored by Muthiah Vaduganathan

Since Specialization

Citations

This map shows the geographic impact of Muthiah Vaduganathan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muthiah Vaduganathan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muthiah Vaduganathan more than expected).

Fields of papers citing papers by Muthiah Vaduganathan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Muthiah Vaduganathan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muthiah Vaduganathan. The network helps show where Muthiah Vaduganathan may publish in the future.

Co-authorship network of co-authors of Muthiah Vaduganathan

This figure shows the co-authorship network connecting the top 25 collaborators of Muthiah Vaduganathan. A scholar is included among the top collaborators of Muthiah Vaduganathan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muthiah Vaduganathan. Muthiah Vaduganathan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Reminders embedded in PCI reports to optimize discharge diabetes mellitus care (REMIND-DM): Rationale, design, and baseline characteristics 2025 ·American Heart Journal ·Safia Chatur, Milan Seth, (unknown), Michael P. Thompson, (unknown), Vishal Gupta, (unknown), (unknown), Anik Forest, Hitinder S. Gurm, Devraj Sukul, Muthiah Vaduganathan	0
2	PROGNOSTIC IMPACT OF HEPATORENAL DYSFUNCTION AND CARDIOVASCULAR-KIDNEYMETABOLIC MULTIMORBIDITY IN HEART FAILURE: A PARTICIPANT-LEVEL POOLED ANALYSIS OF THE PARADIGM-HF AND PARAGON-HF TRIALS 2025 ·Journal of the American College of Cardiology ·(unknown), Maria Pabón, John W. Ostrominski, Brian Claggett, Milton Packer, (unknown), Karl Swedberg, (unknown), Michael R. Zile, Martin Lefkowitz, Akshay S. Desai, Pardeep S. Jhund, John J.V. McMurray, Scott Solomon, Muthiah Vaduganathan	0
3	Obesity, aldosterone, and natriuretic peptides in patients with heart failure and reduced ejection fraction 2025 ·Cardiovascular Research ·Shingo Matsumoto, Jawad H. Butt, Kieran F. Docherty, Pardeep S. Jhund, (unknown), Akshay S. Desai, Lars Køber, Jean-Lucien Rouleau, Milton Packer, Muthiah Vaduganathan, Scott Solomon, John J.V. McMurray	0
4	Screening Natriuretic Peptide Levels Predicts Heart Failure and Death in Individuals With Type 1 and Type 2 Diabetes Without Known Heart Failure 2025 ·Diabetes Care ·Rodica Pop‐Busui, Enrico Repetto, Jason M. Baron, Dagmar Schumacher, Muthiah Vaduganathan, Ambarish Pandey	1
5	Canagliflozin Reduces Oral Loop Diuretic Intensification in Patients with Type 2 Diabetes: A Participant-Level Pooled Analysis of the CANVAS and CREDENCE Trials 2025 ·European Journal of Heart Failure ·Safia Chatur, Muthiah Vaduganathan, Robert A. Fletcher, Vlado Perkovic, Hiddo J.L. Heerspink, Clare Arnott, Carol A. Pollock, Kenneth W. Mahaffey, Bruce Neal, Meg Jardine, Scott D. Solomon, Brendon L. Neuen	1
6	Natriuretic Peptides, Kidney Function, and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction 2024 ·JACC Heart Failure ·Brendon L. Neuen, Muthiah Vaduganathan, Brian Claggett, Iris E. Beldhuis, Peder L. Myhre, Akshay S. Desai, Hicham Skali, Finnian R. Mc Causland, Martina M. McGrath, Inder S. Anand, Michael R. Zile, Marc A. Pfeffer, John J.V. McMurray, Scott D. Solomon	8
7	Bidirectional Relationship Between Kidney Disease Progression and Cardiovascular Events in Type 2 Diabetes 2024 ·Journal of the American College of Cardiology ·Brendon L. Neuen, John W. Ostrominski, Brian Claggett, Iris E. Beldhuis, Safia Chatur, Finnian R. McCausland, Sunil V. Badve, Clare Arnott, Hiddo J.L. Heerspink, Min Jun, Michael O. Falster, Juliana de Oliveira Costa, Carol A. Pollock, Meg Jardine, Kenneth W. Mahaffey, Vlado Perkovic, Scott D. Solomon, Muthiah Vaduganathan	5
8	Sacubitril/Valsartan in Patients With Heart Failure and Deterioration in eGFR to <30 mL/min/1.73 m2 2024 ·JACC Heart Failure ·Safia Chatur, Iris E. Beldhuis, Brian Claggett, Finnian R. McCausland, Brendon L. Neuen, Akshay S. Desai, Jean L. Rouleau, Michael R. Zile, Milton Packer, Marc A. Pfeffer, Martin Lefkowitz, John J.V. McMurray, Scott D. Solomon, Muthiah Vaduganathan	5
9	Race in Heart Failure 2024 ·JACC Heart Failure ·Henri Lu, Brian Claggett, Milton Packer, Maria Pabón, Marc A. Pfeffer, Eldrin F. Lewis, (unknown), Jean L. Rouleau, Michael R. Zile, Martin Lefkowitz, Akshay S. Desai, Pardeep S. Jhund, John J.V. McMurray, Scott D. Solomon, Muthiah Vaduganathan	0
10	Sacubitril/Valsartan-Related Hypotension in Patients With Heart Failure and Preserved or Mildly Reduced Ejection Fraction 2024 ·Journal of the American College of Cardiology ·Alberto Foà, Muthiah Vaduganathan, Brian Claggett, Maria Pabón, Henri Lu, Marc A. Pfeffer, Milton Packer, Orly Vardeny, Jean L. Rouleau, Martin Lefkowitz, Robert J. Mentz, Pardeep S. Jhund, Akshay S. Desai, John J.V. McMurray, Scott D. Solomon	3
11	Generalizability of the Spectrum of Kidney Risk in the FINEARTS-HF Trial to U.S. Adults With Heart Failure 2024 ·Journal of Cardiac Failure ·John W. Ostrominski, Rahul Aggarwal, Brian Claggett, Ian J. Kulac, Akshay S. Desai, Pardeep S. Jhund, Carolyn S.P. Lam, Bertram Pitt, Michele Senni, Sanjiv J. Shah, Adriaan A. Voors, Faı̈ez Zannad, James Lay‐Flurrie, Prabhakar Viswanathan, John J.V. McMurray, Scott D. Solomon, Muthiah Vaduganathan	4
12	Mortality After High-Risk Myocardial Infarction Over the Last 20 Years: Insights from the VALIANT and PARADISE-MI Trials 2024 ·European Journal of Heart Failure ·Alberto Foà, Maria Pabón, Eugene Braunwald, Karola Jering, Muthiah Vaduganathan, Brian Claggett, Lars Køber, Eldrin F. Lewis, Christopher B. Granger, Peter van der Meer, Jean L. Rouleau, Aldo P. Maggioni, John J.V. McMurray, Scott Solomon, Marc A. Pfeffer	3
13	Effect of SGLT2 Inhibitors on Discontinuation of Renin–angiotensin System Blockade: A Joint Analysis of the CREDENCE and DAPA-CKD Trials 2023 ·Journal of the American Society of Nephrology ·Robert A. Fletcher, Niels Jongs, Glenn M. Chertow, John J.V. McMurray, Clare Arnott, Meg Jardine, Kenneth W. Mahaffey, Vlado Perkovic, Patrick Rockenschaub, Peter Rossing, Ricardo Correa‐Rotter, Robert D. Toto, Muthiah Vaduganathan, David C. Wheeler, Hiddo J.L. Heerspink, Brendon L. Neuen	14
14	Contemporary use of cardiovascular risk reduction strategies in type 2 diabetes. Insights from the diabetes collaborative registry 2023 ·American Heart Journal ·Suzanne V. Arnold, Kensey Gosch, Mikhail Kosiborod, Nathan D. Wong, Laurence Sperling, Jonathan Newman, (unknown), (unknown), (unknown), Muthiah Vaduganathan	7
15	Chapter 2: Clinical and Mechanistic Potential of Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors in Heart Failure with Preserved Ejection Fraction 2023 ·The American Journal of Medicine ·John W. Ostrominski, Muthiah Vaduganathan	7
16	Knowledge About Self-Efficacy and Outcomes in Patients with Heart Failure and Reduced Ejection Fraction 2023 ·European Journal of Heart Failure ·Mingming Yang, Toru Kondo, Carly Adamson, Jawad H. Butt, William T. Abraham, Akshay S. Desai, Karola Jering, Lars Køber, Mikhail Kosiborod, Milton Packer, Jean L. Rouleau, Scott D. Solomon, Muthiah Vaduganathan, Michael R. Zile, Pardeep S. Jhund, John J.V. McMurray	3
17	Twenty Year Trends and Sex Differences in Young Adults Hospitalized With Acute Myocardial Infarction breakdown → 2019 ·Circulation ·Sameer Arora, George A. Stouffer, Anna Kucharska‐Newton, Arman Qamar, Muthiah Vaduganathan, Ambarish Pandey, Deborah S Porterfield, Ron Blankstein, Wayne D. Rosamond, Deepak L. Bhatt, Melissa C. Caughey	452
18	Intensive blood pressure lowering in different age categories: insights from the Systolic Blood Pressure Intervention Trial 2019 ·European Heart Journal - Cardiovascular Pharmacotherapy ·Christina Byrne, Manan Pareek, Muthiah Vaduganathan, Tor Biering‐Sørensen, Arman Qamar, Ambarish Pandey, Thomas Bastholm Olesen, Michael Hecht Olsen, Deepak L. Bhatt	12
19	Influence of Documented History of Coronary Artery Disease on Outcomes in Patients Admitted for Worsening Heart Failure with Reduced Ejection Fraction in the EVEREST Trial 2012 ·European Journal of Heart Failure ·Robert J. Mentz, Bradley D. Allen, Mary Kwasny, Marvin A. Konstam, James E. Udelson, Andrew P. Ambrosy, Angela J. Fought, Muthiah Vaduganathan, Christopher M. O’Connor, Faı̈ez Zannad, Aldo P. Maggioni, Karl Swedberg, Robert O. Bonow, Mihai Gheorghiade	20
20	Clinical Course and Predictive Value of Liver Function Tests in Patients Hospitalized for Worsening Heart Failure with Reduced Ejection Fraction: An Analysis of the EVEREST Trial 2012 ·European Journal of Heart Failure ·Andrew P. Ambrosy, Muthiah Vaduganathan, Mark D. Huffman, Sadiya S. Khan, Mary Kwasny, Angela J. Fought, Aldo P. Maggioni, Karl Swedberg, Marvin A. Konstam, Faı̈ez Zannad, Mihai Gheorghiade	146

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact